SNHG12 and cancer: Furthermore, the aggregated data showed that SNHG12 high expression was associated with tumor stage (P < 0.00001), poor cancer outcome (P = 0.01), positive lymph node metastases (P < 0.00001), distant metastases (P = 0.0006), and tumor size (P < 0.00001).